In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.
We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.
Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.
This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.
BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.
The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
The MSF Science Portal is a digital platform for Médecins Sans Frontières to share the medical evidence we gather as part of our medical humanitarian work aiding people and communities affected by conflict, epidemics, disasters, or exclusion from health services.
Doctors Without Borders/Médecins Sans Frontières (MSF) has launched the Transformational Investment Capacity (TIC) to transform our ability to address the most pressing medical and humanitarian challenges around the world.
The Telemedicine program provides secure solutions designed to support the needs of healthcare professionals across MSF, while building a community of knowledge-sharing and clinical collaboration.
Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF, in order to more effectively co-create innovations that save lives and alleviate suffering.
This page is no longer being maintained and was last updated in December 2021.
On 16 December 2021, DRC declared the country’s thirteenth recorded outbreak of Ebola over.
The outbreak, which was located in DRC’s northeast, in North Kivu province, was declared on 8 October. This thirteenth outbreak came five months after the end of the twelfth outbreak, also in North Kivu province. It was the country’s fifth outbreak since May 2018.
MSF teams responded to the outbreak in North Kivu.
In DRC, MSF runs some of its largest medical relief operations, working in 17 of 26 provinces, responding to diseases outbreaks, conflict and displacement, and tackling health problems such as HIV/AIDs.
2.578.300
outpatient consultations
1.495.400
vaccinations against measles in response to an outbreak
779.800
malaria cases treated
29.000
people treated for sexual violence
14.100
surgical interventions
1.410
people with advanced HIV under direct MSF care
Medical activities
Haemorrhagic fevers
Ebola and Marburg haemorrhagic fevers are rare but deadly. Outbreaks can kill 25 to 90 per cent of those infected, spreading fear and panic among affected communities.
Crisis Settings
Epidemics and pandemics
Millions of people still die each year from infectious diseases that are preventable or can be treated.
